Oroho bill on pharmaceutical industry becomes law

TRENTON — Legislation sponsored by Senator Steve Oroho to make the registration process easier for pharmaceutical companies is now law after it was signed by Governor Chris Christie.
The measure came out of the New Jersey Red Tape Review Commission.
“The seemingly never ending list of regulations and rules has handcuffed business in this state for far too long,” Senator Oroho said. “Six years after it was created, the Red Tape Review Commission is still finding ways to cut back the bureaucracy and make it easier for entrepreneurs and job creators to grow their businesses in the state. This law will reduce the time it takes for drug companies to set up shop in New Jersey.”
The Red Tape Review Commission was created by executive order on Gov. Chris Christie’s first day in office. It was tasked with taking a look at the state’s regulations and deciding if their negative impact on businesses outweighed their intended benefits. The commission has continued with this mission since it was made a permanent part of state government in September of 2010.
The legislation, S-2024, clarifies that approval by the U.S. Food and Drug Administration is not required when a drug manufacturer is filing a registration statement. Instead, at the time of filing, the company will only be required to submit a statement confirming that an application has been submitted to the FDA.
“We’ve heard from these businesses, and passing this legislation like this will be key to keeping more companies in operation in New Jersey,” Senator Oroho said. “If we can make government more efficient, we can make the state better for business and cheaper for residents. This law is another step toward that goal, but we must continue our efforts in order to ensure our economic prosperity."